Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
4.
A A Pract ; 17(8): e01700, 2023 Aug 01.
Article in English | MEDLINE | ID: mdl-37616181

ABSTRACT

We report a case of a woman who experienced unexplained recurrent rashes of varying severity after multiple exposures to anesthesia, and then 2 successful surgeries under general anesthesia with no resultant rashes after removing propofol from her anesthetic plans. We infer her previous postanesthetic rashes were likely associated with drug-induced subacute cutaneous lupus erythematosus (DI-SCLE) triggered by propofol.


Subject(s)
Anesthesiology , Exanthema , Lupus Erythematosus, Cutaneous , Propofol , Female , Humans , Propofol/adverse effects , Lupus Erythematosus, Cutaneous/chemically induced , Anesthesia, General
6.
J Cardiothorac Vasc Anesth ; 37(10): 1850-1851, 2023 10.
Article in English | MEDLINE | ID: mdl-37385882
8.
Pulm Ther ; 9(1): 109-126, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36670314

ABSTRACT

Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is a form of mechanical life support that provides full respiratory bypass in patients with severe respiratory failure as a bridge to recovery or lung transplantation. The use of ECMO for respiratory failure and capable centers offering ECMO has expanded over the years, increasing its availability. As VV-ECMO provides an artificial mechanism for oxygenation and decarboxylation of native blood, it allows for an environment in which safer mechanical ventilatory care may be provided, allowing for treatment and resolution of underlying respiratory pathologies. Landmark clinical trials have provided a framework for better understanding patient selection criteria, resource utilization, and outcomes associated with ECMO when applied in settings of refractory respiratory failure. Maintaining close vigilance and management of complications during ECMO as well as identifying strategies post-ECMO (e.g., recovery, transplantation, etc.), are critical to successful ECMO support. In this review, we examine considerations for candidate selection for VV-ECMO, review the evidence of utilizing VV-ECMO in respiratory failure, and provide practical considerations for managing respiratory ECMO patients, including complication identification and management, as well as assessing for the ability to separate from ECMO support and the procedures for decannulation.

16.
J Cardiothorac Vasc Anesth ; 36(1): 321-331, 2022 01.
Article in English | MEDLINE | ID: mdl-33975792

ABSTRACT

Unilateral pulmonary edema (UPE) is an uncommon yet potentially life-threatening complication of minimally invasive cardiac surgery (MICS). Most frequently described after robotically assisted mitral valve (MV) repair, it is characterized by right lung edema, hypoxemia, hypercapnia, pulmonary hypertension, and hemodynamic instability beginning minutes-to-hours after separation from cardiopulmonary bypass (CPB). The authors describe a severe case with refractory hypoxemia requiring veno-venous (VV) extracorporeal membrane oxygenation (ECMO) after robotically assisted MV repair.


Subject(s)
Cardiac Surgical Procedures , Extracorporeal Membrane Oxygenation , Pulmonary Edema , Robotic Surgical Procedures , Cardiac Surgical Procedures/adverse effects , Extracorporeal Membrane Oxygenation/adverse effects , Humans , Mitral Valve/diagnostic imaging , Mitral Valve/surgery , Pulmonary Edema/diagnostic imaging , Pulmonary Edema/etiology , Robotic Surgical Procedures/adverse effects
18.
J Cardiothorac Vasc Anesth ; 36(1): 58-65, 2022 01.
Article in English | MEDLINE | ID: mdl-34696968

ABSTRACT

This paper is the first of a four-part series that details the current barriers to diversity in the field of adult cardiothoracic anesthesiology and outlines actionable programs that can be implemented to create change. Part I and Part II address the training experience of women and underrepresented minorities (URMs) in adult cardiothoracic anesthesiology (ACTA), respectively, and explore concrete opportunities to promote positive change. Part III and Part IV examine the professional experience of URMs and women in ACTA, respectively, and discuss interventions that can facilitate a more equitable and inclusive environment for both groups. Although these problems are complex, the authors here offer a detailed analysis of the challenges faced by each group both in the training phase and the professional practice phase of their careers. The authors also present meaningful and concrete actions that can be implemented to create a more diverse, equitable, and inclusive professional environment in cardiovascular and thoracic anesthesiology.


Subject(s)
Anesthesiology , Fellowships and Scholarships , Adult , Female , Humans , Minority Groups
SELECTION OF CITATIONS
SEARCH DETAIL
...